Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Egansbay
    Member
    • Jan 2015
    • 23

    #1

    16S V4 amplicon concentration after first PCR step

    Dear all

    I am analyzing gut samples from fish using illumina's 16S protocol, amplifying the v4 hypervariable region. I am getting ok bands after the first PCR step, and a nice peak on the agilent bioanalyzer (approx. 350bp). I am wondering however, after purification of products, what is an acceptable concentration for each sample? I am getting concentrations of individual products of between 0.5 and 9ng/ul, with the average being around 2-4ng/ul per sample. Is this an acceptable concentration to proceed with?

    Thank you very much in advance.

    Kind regards

    Egansbay
  • microgirl123
    Senior Member
    • Jun 2012
    • 199

    #2
    Hi Egansbay,

    I usually quantify my first round PCR products with Qubit and then try to add 50 ng of total DNA to the second round of PCR for 5 cycles. If my concentrations are much too low to do that, I add up to 3 more cycles of PCR.

    Comment

    • Egansbay
      Member
      • Jan 2015
      • 23

      #3
      Thank you microgirl. So in your experience are my concentrations of product too low to proceed with second round pcr?

      Comment

      • microgirl123
        Senior Member
        • Jun 2012
        • 199

        #4
        If you had good bands in the first place, I would go ahead and give it a try - you can always do a few samples first. I use an adaptation of the Illumina method with a 50 ul PCR volume, up to 15 ul of cleaned template, and 5-8 cycles of PCR.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        36 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        43 views
        0 reactions
        Last Post SEQadmin2  
        Working...